Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INVESCO LTD.

(IVZ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Invesco ltd: Form 8.3 - Xeris Pharmaceutical Inc.

09/20/2021 | 07:15am EDT

                        

Form 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION

Name of person dealing (Note 1)Invesco Ltd.
Company dealt inXeris Pharmaceuticals, Inc.
Class of relevant security to which the dealings being disclosed relate (Note 2)Common Stock US98422L1070
Date of dealing17-9-2021
  1. INTERESTS AND SHORT POSITIONS

(a)    Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 LongShort
 Number (%)Number       (%)
(1) Relevant securities2,036,814        3.063%      
(2) Derivatives (other than options)  
(3) Options and agreements to purchase/sell  
Total2,036,814 3.063% 

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:LongShort
 No. (%)Number       (%)
(1) Relevant securities  


(2) Derivatives (other than options)
  


(3) Options and agreements to purchase/sell
  
Total  

        

1.    DEALINGS (Note 4)


(a)    Purchases and sales



Purchase/sale


Number of relevant securities


Price per unit (Note 52
Sale492.60 USD
   
   

(b)    Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)
    

(c)    Options transactions in respect of existing relevant securities

(i)    Writing, selling, purchasing or varying

Product name,
e.g. call option
Writing, selling, purchasing, varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)
       

(ii)    Exercising

Product name,

e.g. call option
Number of securitiesExercise price per unit (Note 5)
   

(d)    Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
DetailsPrice per unit

(if applicable) (Note 5)
   

    2.    OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            NO

Date of disclosure20-09-2021
Contact namePhilippa Holmes
Telephone number01491 417 447
If a connected EFM, name of offeree/offeror with which connectedN/A
If a connected EFM, state nature of connection (Note 10) 


© OMX, source GlobeNewswire - EU Press Releases

Stocks mentioned in the article
ChangeLast1st jan.
INVESCO LTD. -0.49% 25.435 Delayed Quote.46.70%
XERIS BIOPHARMA HOLDINGS, INC. -2.60% 1.87 End-of-day quote.-61.99%
All news about INVESCO LTD.
04:49aInvesco Launches ESG-Weighted QQQ ETF in Europe
MT
10/26Invesco Says FX Rates Reduced Assets in 3Q -- Currency Comment
DJ
10/26Citigroup Adjusts Invesco's Price Target to $35 from $33.50, Keeps Buy Rating
MT
10/26CTS EVENTIM AG & CO. KGAA : Release according to Article 40, Section 1 of the WpHG [the Ge..
DJ
10/26SMA SOLAR TECHNOLOGY AG : Release according to Article 40, Section 1 of the WpHG [the Germ..
DJ
10/26Indian court restrains Invesco from calling shareholders meeting in win for Zee
RE
10/26Financial Stocks Advance Pre-Bell Tuesday
MT
10/26Invesco Announces Third Quarter Diluted EPS of $0.71; Adjusted Diluted EPS(1) of $0.77 ..
PU
10/26INVESCO LTD. : Results of Operations and Financial Condition, Financial Statements and Exh..
AQ
10/26Invesco Posts Higher Q3 Results
MT
More news
Analyst Recommendations on INVESCO LTD.
More recommendations
Financials (USD)
Sales 2021 5 226 M - -
Net income 2021 1 366 M - -
Net Debt 2021 4 586 M - -
P/E ratio 2021 9,19x
Yield 2021 2,63%
Capitalization 11 798 M 11 798 M -
EV / Sales 2021 3,13x
EV / Sales 2022 2,77x
Nbr of Employees 8 483
Free-Float 67,0%
Chart INVESCO LTD.
Duration : Period :
Invesco Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVESCO LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 25,57 $
Average target price 30,42 $
Spread / Average Target 19,0%
EPS Revisions
Managers and Directors
Martin L. Flanagan President, Chief Executive Officer & Director
L. Allison Dukes Senior Managing Director & Chief Financial Officer
G. Richard Wagoner Chairman
Nicholas Buss Senior Director-Research
Gregory Gerard McGreevey Senior Managing Director-Investments
Sector and Competitors
1st jan.Capi. (M$)
INVESCO LTD.46.70%11 798
BLACKSTONE INC.119.35%102 550
KKR & CO. INC.89.06%44 631
LEGAL & GENERAL PLC8.49%23 625
THE CARLYLE GROUP INC.79.04%20 096
AMUNDI17.29%18 389